371 filings
6-K
TLSA
Tiziana Life Sciences Ltd
11 Jun 24
FDA Accepts Tiziana Life Sciences Fast Track Designation Submission for Treatment of Multiple Sclerosis
8:33am
6-K
TLSA
Tiziana Life Sciences Ltd
6 Jun 24
Report of Foreign Private Issuer
9:00am
6-K
TLSA
Tiziana Life Sciences Ltd
4 Jun 24
Report of Foreign Private Issuer
9:00am
6-K
TLSA
Tiziana Life Sciences Ltd
30 May 24
Tiziana Life Sciences Scientific Board Chairman to Receive Prestigious Award for Multiple Sclerosis Research
7:00am
6-K
TLSA
Tiziana Life Sciences Ltd
13 May 24
Report of Foreign Private Issuer
7:00am
20-F
2023 FY
TLSA
Tiziana Life Sciences Ltd
Annual report (foreign)
10 May 24
5:00pm
NT 20-F
TLSA
Tiziana Life Sciences Ltd
30 Apr 24
Notice of late annual filing (foreign)
5:00pm
6-K
TLSA
Tiziana Life Sciences Ltd
25 Apr 24
Tiziana Life Sciences Reports Positive 3-Month Neuroimaging Scores in Multiple Sclerosis Patients Receiving Intranasal Foralumab
10:00am
6-K
TLSA
Tiziana Life Sciences Ltd
23 Apr 24
Report of Foreign Private Issuer
7:00am
6-K
TLSA
Tiziana Life Sciences Ltd
22 Apr 24
Tiziana Life Sciences Announces Additional Clinical Improvements Among Multiple Sclerosis Patients in its Expanded Access Program
10:10am
6-K
TLSA
Tiziana Life Sciences Ltd
19 Apr 24
Report of Foreign Private Issuer
7:00am
6-K
TLSA
Tiziana Life Sciences Ltd
18 Apr 24
Tiziana Life Sciences Announces New Quantitative PET Imaging Data on Foralumab at the Annual Meeting of the American Academy of Neurology
7:00am
6-K
TLSA
Tiziana Life Sciences Ltd
11 Apr 24
Report of Foreign Private Issuer
7:00am
6-K
TLSA
Tiziana Life Sciences Ltd
5 Mar 24
Tiziana Life Sciences Announces Podium Presentation at AD/PD of Nasal Anti-CD3 in Alzheimer’s Disease
7:00am
6-K
TLSA
Tiziana Life Sciences Ltd
8 Jan 24
Tiziana Life Sciences Announces Updated Clinical and PET Scan Findings for Intranasal Foralumab in Two New Multiple Sclerosis Patients
7:00am
6-K
TLSA
Tiziana Life Sciences Ltd
5 Jan 24
Report of Foreign Private Issuer
9:30am
6-K
TLSA
Tiziana Life Sciences Ltd
5 Jan 24
Report of Foreign Private Issuer
7:00am
6-K
TLSA
Tiziana Life Sciences Ltd
29 Dec 23
Updated Interim Results for the Six Months Ended 30 June 2023
4:30pm
6-K
TLSA
Tiziana Life Sciences Ltd
19 Dec 23
Report of Foreign Private Issuer
7:00am
6-K
TLSA
Tiziana Life Sciences Ltd
4 Dec 23
Report of Foreign Private Issuer
7:00am